CARDIOCEQ

Swiss trademark · 763552 · Word mark · In force

Register entry

Registration number
763552
Application number
17251/2020
Status
In force
Type
Word mark
Filed
Dec 3, 2020
Registered
May 11, 2021
Published
May 11, 2021
Protected until
Dec 3, 2030
Source
Swissreg

Goods and services

Pharmaceuticals

Diagnostische Mittel, Präparate und Substanzen für medizinische Zwecke; Diagnostikmittel für medizinische Zwecke.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 4, 2026

    Holder’s address changed

    Owner
    Life Molecular Imaging Limited, 25 Barnes Wallis Road, Fareham, P015 5TT Hampshire, United Kingdom → Lantheus Biosciences Ltd., 25 Barnes Wallis Road, Fareham, P015 5TT Hampshire, United Kingdom

    Published in Swissreg on 04.09.2026

  2. Oct 3, 2024

    Holder’s address changed

    Owner
    Life Molecular Imaging Limited, First Floor, The Woods, Opus 40 Business Park, Warwick CV34 5AH, United Kingdom → Life Molecular Imaging Limited, 25 Barnes Wallis Road, Fareham, P015 5TT Hampshire, United Kingdom

    Published in Swissreg on 03.10.2024

  3. May 10, 2023

    Holder’s address changed

    Owner
    Life Molecular Imaging Limited, Iceni Centre, Warwick Technology Park, Warwick, CV 34 6DA, United Kingdom → Life Molecular Imaging Limited, First Floor, The Woods, Opus 40 Business Park, Warwick CV34 5AH, United Kingdom

    Published in Swissreg on 10.05.2023

  4. Jul 22, 2022

    Transferred

    Owner
    Life Molecular Imaging SA, c/o Pascale Nguyen, Route de l'Ecole 13, 1753 Matran → Life Molecular Imaging Limited, Iceni Centre, Warwick Technology Park, Warwick, CV 34 6DA, United Kingdom

    Published in Swissreg on 22.07.2022

  5. May 11, 2021

    Registered

    Published in Swissreg on 11.05.2021

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.